Gelonghui September 21, Haitong pointed out that 002603.SZ has a number of patented traditional Chinese medicines in the fields of cardio-cerebrovascular and respiratory to form a unique product layout, as well as a competitive advantage in scientific research under the guidance of collateral disease theory. In the future, a number of innovative traditional Chinese medicine will be introduced one after another, maintaining the "better than the market" rating. Up to now, the company has a total of 13 patented varieties of traditional Chinese medicine, of which 10 are listed in the national medical insurance catalogue and 5 in the national essential medicine catalogue, laying a good foundation for the company to maintain sustained and rapid growth in the next few years. On the other hand, the company continues to carry out post-market re-evaluation and secondary development of listed traditional Chinese medicine varieties, and listed varieties continue to carry out in-depth discussion of pharmacodynamic mechanism, post-market evidence-based medicine evaluation and real-world research to further enhance the clinical value of the products.